Upcoming Event
The 7th Annual Allogeneic Cell Therapies Summit
Date:
June 10-12, 2025Location:
Boston, Massachusetts
Schedule a meeting with our team during the 7th Annual Allogeneic Cell Therapies Summit.
The 7th Annual Allogeneic Cell Therapies Summit will address the critical challenges in optimizing complex gene engineering, ensuring the safety and potency of off-the-shelf cell therapies to accelerate your path to clinical and commercial success.
Meet with our team to:
- Explore how our continuum of capabilities and expertise in process and analytical development, training, QC, and scalable manufacturing capabilities can help you meet your goals at any stage, from early-stage development to commercial manufacturing.
- Learn how our intelligent factor model integrates automation and AI to scale your cell therapy programs, transforming CMC.
Our team looks forward to gathering with pharmaceutical and biotech industry leaders to discover how to work together to enable accessibility and affordability.
Have questions about our cell and gene therapy CDMO services? Contact us at cdmo@omniabio.com.
About OmniaBio
As a dedicated cell and gene therapy CDMO, OmniaBio's vision is to manufacture a disease-free future. Headquartered in Ontario, Canada, our core values of collaborative partnership converge with deep industry experience and innovation using the latest technologies to drive the future of cell and gene therapy manufacturing.
© 2025 OmniaBio | Privacy Policy
